European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- Online

A central purpose of Ph. Eur. 0478 is defining the physical tests that finished batches must satisfy. The monograph cross-references vital technical chapters to govern structural durability and mass reproducibility: The Ph.Eur. approach to tablet splitting

For a pharmaceutical manufacturer, is more than a technical document. It is the legal gateway to sell tablets in Europe. If your QC report claims "Conforms to Ph. Eur. 0478," you are legally declaring that every batch released meets the standards for:

By adopting the standards and guidelines set out in the "Tablets -0478-" monograph, the pharmaceutical industry can ensure that tablets are produced and controlled to a high standard, ultimately benefiting patients and public health. European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

This ensures each tablet contains the correct amount of active ingredient. It often involves testing for Uniformity of Mass or Content.

Monograph defines tablets as solid pharmaceutical dosage forms containing a single dose of one or more active substances. They are typically obtained by compressing uniform volumes of particles and are intended for oral administration, though some sub-types may be intended for other routes. Core Quality Requirements A central purpose of Ph

| Parameter | Ph. Eur. 0478 | USP <701>/<711> | JP (General Tests) | | :--- | :--- | :--- | :--- | | Disintegration time (uncoated) | 15 min | 15 min (but often 30 min for large tabs) | 15 min | | Dissolution vessel volume | 900 mL (preferred) | 500, 900, or 1000 mL | 900 mL | | Friability acceptance | 1.0% (uncoated) | 1.0% (but 0.8% for high-use) | 1.0% | | Uniformity of dosage units | AV ≤ 15.0 (2.9.40) | AV ≤ 15.0 (identical via ICH Q4B) | AV ≤ 15.0 |

Many of the general methods cross-referenced in Monograph 0478 (such as Dissolution 2.9.3 and Uniformity of Dosage Units 2.9.40) have undergone extensive harmonization. This reduces the burden on international manufacturers, allowing them to utilize streamlined testing protocols that satisfy multiple regulatory jurisdictions simultaneously. If your QC report claims "Conforms to Ph

is a general dosage form monograph that establishes the mandatory quality standards for tablets intended for oral administration in the European Union. It covers a wide range of tablet types, including uncoated, coated, effervescent, gastro-resistant, and orodispersible tablets. www.edqm.eu Core Definitions & Scope Definition

Must show no signs of disintegration or cracks when exposed to 0.1 M hydrochloric acid for 2 hours, but must disintegrate in a phosphate buffer solution (pH 6.8) within 60 minutes.

: Ensures each tablet contains the correct amount of active ingredient. This is generally verified through Uniformity of Mass or Uniformity of Content .